Quinazoline based 1,3,5-triazine derivatives as cancer inhibitors by impeding the phosphorylated RET tyrosine kinase pathway: Design, synthesis, docking, and QSAR study

Archiv der Pharmazie
Prateek PathakVladimir Potemkin

Abstract

The present research focused on designing a quinazoline skeleton, framed via 1,3,5-triazine derivatives (QBT) through field mapping and alignment studies. The QBT derivatives were synthesized via time- and cost-effective protocol. The 3D-QSAR study, computational physicochemical properties, and ADME calculation of the derivatives were performed to establish the affinity towards the biological system. Molecular docking in the adenosine triphosphate binding site of the RET tyrosine kinase domain (PDB ID: 7IVU) was studied to elucidate vital structural residues necessary for bioactivity. The derivatives were evaluated for anticancer potency against TPC-1 cells (thyroid cancer), MCF-7 cells (breast cancer), and one normal cell line (human foreskin fibroblasts) via 3-(4,5-dimethylthiazol-2-y1)-2,5-diphenyltetrazolium bromide assay followed by an in ovo CAM assay. The entire series of derivatives (8a-o) showed mild to significant anticancer potency against the selected cancer cell lines.

References

Jan 1, 1968·Journal of Medicinal Chemistry·H J HessA Scriabine
Mar 28, 2006·Journal of Chemical Information and Modeling·Tim CheeserightAndy Vinter
Aug 30, 2008·Drug Discovery Today·Vladimir Potemkin, Maria Grishina
Jun 2, 2009·Chemical & Pharmaceutical Bulletin·Lyudmila AntipenkoAleksey Chekotilo
Aug 12, 2009·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·L Krenn, D H Paper
Dec 17, 2009·European Journal of Medicinal Chemistry·Rondla RohiniVadde Ravinder
Oct 15, 2010·Bioorganic & Medicinal Chemistry Letters·Ying YangHai-Liang Zhu
Dec 29, 2010·Indian Journal of Pharmaceutical Sciences·P PaneersalvamB A Rather
Aug 27, 2011·Chemistry & Biology·Deborah BalzanoFabrizio Villa
Dec 28, 2011·Bioorganic & Medicinal Chemistry Letters·Syed Umar Farooq RizviInamullah Khan
Apr 11, 2012·Bioorganic & Medicinal Chemistry Letters·Sanjita SasmalThomas Högberg
Jun 23, 2012·Clinical Medicine Insights. Oncology·Nils DegrauweHari A Deshpande
Jul 4, 2012·European Journal of Medicinal Chemistry·Junbo HeLiwu Fu
Dec 25, 2012·Gastrointestinal Endoscopy·Elizabeth A RajanAshley L Faulx
Jan 1, 2007·Expert Opinion on Drug Discovery·Tim CheeserightAndy Vinter Phd
Jun 5, 2013·Chemistry Central Journal·Dan Wang, Feng Gao
Jul 13, 2013·Bioorganic & Medicinal Chemistry Letters·Pascal DaoHuixiong Chen
Aug 1, 2013·European Journal of Medicinal Chemistry·Maria Teresa ConconiAdriana Chilin
Dec 1, 2004·Drug Discovery Today. Technologies·Christopher A Lipinski
Sep 24, 2014·Animal : an International Journal of Animal Bioscience·S DiverioM M Santoro
Jan 28, 2017·Scientific Reports·Michiru NishitaYasuhiro Minami
Feb 9, 2017·Current Drug Discovery Technologies·Andrey V PotemkinVladimir A Potemkin
Mar 10, 2018·Current Medicinal Chemistry·Vladimir Potemkin, Maria Grishina

❮ Previous
Next ❯

Citations

Sep 9, 2020·Journal of Biomolecular Structure & Dynamics·Prateek PathakVladimir Potemkin
Apr 25, 2020·Orphanet Journal of Rare Diseases·Davide MaraghelliMaria Luisa Brandi
Feb 3, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Swapnil P BhujbalSeung Joo Cho

❮ Previous
Next ❯